We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.04B
AUM Growth
+$106M
Cap. Flow
+$157M
Cap. Flow %
3.9%
Top 10 Hldgs %
19.27%
Holding
766
New
131
Increased
235
Reduced
189
Closed
186

Top Buys

Rank Stock Value
1
BBH icon
VanEck Biotech ETF
BBH
+$134M
2
AMGN icon
Amgen
AMGN
+$27M
3
WMB icon
Williams Companies
WMB
+$22.5M
4
XOM icon
ExxonMobil
XOM
+$14.7M
5
AES icon
AES
AES
+$13.6M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$24.1M
2
CME icon
CME Group
CME
+$22.7M
3
CXT icon
Crane NXT
CXT
+$13.5M
4
AFG icon
American Financial Group
AFG
+$11.8M
5
VZ icon
Verizon
VZ
+$8.71M

Sector Composition

Rank Sector Weight
1 Financials 18.44%
2 Technology 13.83%
3 Industrials 11.98%
4 Healthcare 11.68%
5 Consumer Staples 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WIN
551
DELISTED
Windstream Holdings Inc
WIN
$159K ﹤0.01%
8,217
-69
-0.8% -$1.67K
SLM icon
552
SLM Corp
SLM
$5.21B
$154K ﹤0.01%
+13,378
New +$152K
OFG icon
553
OFG Bancorp
OFG
$2.26B
$153K ﹤0.01%
15,265
-5,828
-28% -$61.2K
FTR
554
DELISTED
Frontier Communications Corp.
FTR
$151K ﹤0.01%
8,695
– –
ARTX
555
DELISTED
Arotech Corporation
ARTX
$149K ﹤0.01%
+41,915
New +$138K
GERN icon
556
Geron
GERN
$872M
$148K ﹤0.01%
+53,400
New +$142K
GYRE icon
557
Gyre Therapeutics
GYRE
$692M
$147K ﹤0.01%
+4,209
New +$151K
INWK
558
DELISTED
InnerWorkings, Inc.
INWK
$146K ﹤0.01%
+12,594
New +$135K
FOLD
559
DELISTED
Amicus Therapeutics
FOLD
$145K ﹤0.01%
+14,419
New +$116K
PGNX
560
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$145K ﹤0.01%
+21,322
New +$157K
TPST icon
561
Tempest Therapeutics
TPST
$14.3M
$140K ﹤0.01%
+31
New +$131K
KEYW
562
DELISTED
The KEYW Holding Corporation
KEYW
$138K ﹤0.01%
+14,732
New +$134K
WTI icon
563
W&T Offshore
WTI
$504M
$131K ﹤0.01%
66,916
+27,270
+69% +$59.4K
MERC icon
564
Mercer International
MERC
$49.3M
$128K ﹤0.01%
+11,120
New +$129K
PGH
565
DELISTED
Pengrowth Energy Corporation
PGH
$127K ﹤0.01%
160,118
-470
-0.3% -$428
AMLP icon
566
Alerian MLP ETF
AMLP
$12.9B
$125K ﹤0.01%
+2,089
New +$127K
DO
567
DELISTED
Diamond Offshore Drilling
DO
$124K ﹤0.01%
+11,430
New +$152K
GSS
568
DELISTED
Golden Star Resources Ltd.
GSS
$123K ﹤0.01%
+37,753
New +$135K
GOGL
569
DELISTED
Golden Ocean Group
GOGL
$118K ﹤0.01%
+17,535
New +$120K
CFMS
570
DELISTED
Conformis, Inc. Common Stock
CFMS
$117K ﹤0.01%
1,091
– –
SWN
571
DELISTED
Southwestern Energy Company
SWN
$105K ﹤0.01%
+17,214
New +$119K
INFI
572
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$101K ﹤0.01%
+64,586
New +$125K
ADXS
573
DELISTED
Advaxis Inc
ADXS
$80K ﹤0.01%
821
– –
OMED
574
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$80K ﹤0.01%
23,997
-68
-0.3% -$282
ANW
575
DELISTED
Aegean Marine Petroleum Network
ANW
$71K ﹤0.01%
+12,069
New +$106K
21 22
23
24 25

Similar funds

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Zacks Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Zacks Investment Management held 766 positions worth $4.04B, up 2.7% from $3.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Zacks Investment Management deployed $157M of net new capital in Q2 2017, opening 131 new positions and adding to 235 existing holdings. Its largest new stake was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Exelon, an estimated $24.1M trimmed.

  • Zacks Investment Management's largest Q2 2017 buy was VanEck Biotech ETF: 1,114,205 shares worth $1.12M.
  • Zacks Investment Management added most to Amgen in Q2 2017, an estimated $27M increase.
  • Zacks Investment Management's biggest Q2 2017 reduction was Exelon, cutting an estimated $24.1M.
  • Zacks Investment Management fully exited Crane NXT in Q2 2017, selling an estimated $13.5M.
  • Zacks Investment Management's ten largest holdings make up 19% of its $4.04B portfolio in Q2 2017.
  • Zacks Investment Management opened 131 new positions and closed 186 in Q2 2017.
  • Zacks Investment Management's portfolio value rose 2.7% quarter-over-quarter to $4.04B.

Based on Zacks Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.